发明名称 Melanocortin 1 receptor selective compounds
摘要 A compound of the general formula (1): wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are H or methyl, R13, R14, R15 and R16 are H or alkyl, wherein L1 and L2 are linkers selected from single bond, methyl, ethyl, wherein R19, R20 and R21 are H or -CH 2 X, NT is selected from H, hydroxyl, alkyl, aminoacid, aminoacid analogue, polypeptide and functional group, CT is selected from hydrogen, hydroxyl, alkyl, aminoacid, aminoacid analogue, polypeptide and functional group shows high selectivity and high affinity for MC1-receptors in combination with effective stimulation or inhibition of cAMP formation in MC1-receptor expressing cells but low affinity for other subtypes of MC-receptors and may be used to treat a wide range of inflammatory conditions. Also disclosed is a DNA molecule and a corresponding vector encoding the compound, a fusion protein comprising a copy of it, a vector comprising DNA encoding the fusion protein, and a pharmaceutical composition comprising the compound.
申请公布号 AU3722299(A) 申请公布日期 1999.11.23
申请号 AU19990037222 申请日期 1999.05.05
申请人 WA PHARM AB 发明人 MICHAEL SZARDENINGS;RUTA MUCENIECE;ILZE MUTULE;FELIKSS MUTULIS;JARL WIKBERG
分类号 C12N15/09;A61K38/00;A61K38/22;A61P17/00;A61P29/00;A61P37/02;A61P37/08;A61P43/00;C07K14/685;C07K19/00;C12N15/16 主分类号 C12N15/09
代理机构 代理人
主权项
地址